170385 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details alpha-Glycoproteins
HRG MEASURING METHOD USING ANTI-HRG MONOCLONAL ANTIBODIES
#2MASS SPECTROMETRY METHODS FOR DETERMINING GLYCOPROTEOFORM-BASED BIOMARKERS
#3Methods for Sample Quality Assessment
#4COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PARKINSON'S DISEASE
#5BIOMARKER FOR DIAGNOSING CANCER AND USE THEREOF
#6BIOMARKER FOR CANCER DIAGNOSIS AND USE THEREOF
#7DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES
#8DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES
#9ASSAYS FOR ALPHA-DYSTROGLYCAN GLYCOSYLATION AND METHODS FOR USING SAME
#10METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DYING FROM BREAST CANCER OR PROSTATE CANCER
#11INTEGRATED METHOD FOR URINARY PROSTATE SPECIFIC ANTIGEN N-GLYCOSYLATION PROFILING BY CAPILLARY ELECTROPHORESIS
#12METHODS FOR DIAGNOSING AND DIFFERENTIATING SYNUCLEINOPATHIES
#13DIAGNOSTIC ASSAYS FOR MOVEMENT DISORDERS
#14COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#15METHODS FOR POLYPEPTIDE PROCESSING AND ANALYSIS
#16DETECTION OF DEBRIS IN RECIRCULATING PHAGOCYTES
#17URINARY GLYCOPROTEINS FOR THE EARLY DETECTION AND TREATMENT OF AGGRESSIVE PROSTATE CANCER
#18NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM
#19METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
#20RECOMBINANT GLYCAN BINDING PROTEINS
#21Biomarker of polycystic kidney disease and uses thereof
#22Biomarkers for the diagnosis of invasive fungal infections
#23COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#24PERIODONTITIS DIAGNOSTIC METHODS, USES AND KITS
#25METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#26Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof
#27NMR measurements of NMR biomarker GlycA
#28Diagnosis of Liver Pathology Through Assessment of Protein Glycosylation
#29GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS
#30Biomarkers for Typing Allograft Recipients
#31ROBUST PANELS OF COLORECTAL CANCER BIOMARKERS
#32PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS
#33EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE
#34Modified Fc gamma receptor type III (FcgammaIII, HNA-1) polypeptides and the uses thereof
#35Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
#36COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#37Diagnostic method of liver cancer using α-fetoprotein derived glycopeptides by mass spectrometry
#38A CELL-BASED ARRAY PLATFORM
#39Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
#40Measurement of glycoprotein
#41Measurement of glycoprotein
#42METHODS RELATED TO ADALIMUMAB
#43Biomarker of polycystic kidney disease and uses thereof
#44Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using the same
#45Prostate cancer markers and uses thereof
#46METHOD FOR IN VITRO EXPANSION OF ERYTHROID CELLS
#47Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#48METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#49Sialylated fetuin-A as a marker of immunotherapy efficacy
#50Compositions and methods for treating eye infections and disease
#51Glycan conjugates and use thereof
#52Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
#53Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using the same
#54Compositions and methods for treating eye infections and disease
#55Sandwich assay using labeled lectin and kit therefor
#56Modified Fc gamma receptor type III (FCγIII, HNA-1) polypeptides and the uses thereof
#57Biomarkers associated with schizophrenia
#58NMR measurements of NMR biomarker GlycA
#59Diagnosis of liver pathology through assessment of protein glycosylation
#60DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
#61BIOMARKER FOR RHEUMATOID ARTHRITIS DIAGNOSIS OR ACTIVITY EVALUATION
#62Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
#63Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#64GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF
#65Methods and reagents for glycoproteomics
#66ARRY-520 FOR USE IN TREATING CANCER IN A PATIENT WITH LOW AAG
#67GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF
#68Method for in vitro expansion of erythroid cells
#69IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS
#70Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#71CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS
#72Retrieval of biological materials from the human uterus, ovary and cervix by suction
#73Methods for diagnosis and prognosis of renal injury and renal failure
#74Markers of papillary and reticular fibroblasts and uses thereof
#75Mass spectrometer and mass spectrometric method
#76Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#77NMR measurements of NMR biomarker GlycA
#78Biomarkers associated with nephropathy
#79Method of detecting a urine protein fragment and a serum protein fragment
#80Fertilization prediction and promotion
#81Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#82Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#83Method for evaluating renal status by determining beta-2-glycoprotein 1
#84METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#85DIAGNOSIS OF LIVER PATHOLOGY THROUGH ASSESSMENT OF PROTEIN GLYCOSYLATION
#86Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
#87METHODS FOR DIAGNOSING ELEVATED RIGHT OR LEFT VENTRICULAR FILLING PRESSURE
#88CANCER DIAGNOSIS METHOD USING THE GLYCOSYLATION OF A GLYCOPROTEIN
#89SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#90Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#91Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#92PANCREATIC CANCER MARKERS
#93Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#94BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#95URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
#96Biomarkers associated with nephropathy
#97BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#98Urine and serum biomarkers associated with diabetic nephropathy
#99Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#100Diagnosis of liver pathology through assesment of protein glycosylation
#101Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
#102BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#103Urine and serum biomarkers associated with diabetic nephropathy
#104Glycoprotein Profiling of Bladder Cancer
#105Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
#106Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof
#107Determination of the integrity of RNA
#108DIAGNOSTIC TEST FOR HEPATOCELLULAR CARCINOMA
#109Diagnosis of liver pathology through assessment of protein glycosylation
#110Method for identifying type I diabetes mellitus in humans
#111Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#112Glycoprotein VI antibodies and methods of use thereof
#113Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#114RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#115Diagnosis of liver pathology through assessment of protein glycosylation
#116Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
#117Glycoproteins having lipid mobilising properties and therapeutic applications thereof
#118Method for diagnosing obstructive sleep apnea
#119Clinical assays for thrombospondin fragments in the detection, diagnosis, and evaluation of cancer